7/15/2021Kintor Pharma Ties Up with Fosun for Covid-19 Treatment Proxalutamide ...

7/15/2021China Reportedly Eyeing BioNTech COVID-19 Vaccine as Booster for Its P...

7/15/2021HUTCHMED's MAA for Surufatinib Validated by the European Medicines Age...

7/15/2021CANbridge's CAN106 IND Approved in China for Paroxysmal Nocturnal Hemo...

7/15/2021A Chinese I/O Biotech Looking To Turn Around An Old Novartis Program G...

7/14/2021PharmaDJ's China Licensing Deals Tracker: May 2021

7/14/2021NMPA Announces OTC Switch of Four Rx Drug Products

7/14/2021Innovent and Ascentage Reach Strategic Deal for Olverembatinib in Chin...

7/14/2021Teva's NDA for Copaxone Injection Accepted by the Chinese CDE

7/14/2021AstraZeneca Granted Chinese Approval for New SCLC Indication of Imfinz...

7/13/2021New Report: Global and Chinese CDMO Markets to Rise 11.2% and 19.9% CA...

7/13/2021Biogen Licenses Certain Rights of Anticancer Orelabrutinib from InnoCa...

7/13/2021Kintor Pharma Greenlighted for Pyrilutamide's Phase II Trial in the US

7/13/2021Everest Medicines and Tencent Enters Strategic Commercial Partnership

7/13/2021Takeda's NSCLC Drug Mobocertinib NDA Accepted with Priority Review in ...

7/13/2021CDE Seeks Comments on Draft ICH Guidelines S12

7/13/2021PharmaDJ's China Market Approval Tracker: May 2021

7/13/2021Patent Linkage System in China: Judicial Provisions and Administrative...

7/13/2021Nikkei: Avigan Maker Fujifilm Faces Patent Risk from China's AMMS

7/13/2021Seizing Opportunities in China's Healthcare Sector

7/12/2021Eli Lilly and Tencent Enter Digital MedPharm Partnership in China

7/12/2021Gilead Sciencesand JD Health Enter Strategic Partnership for Digital H...

7/11/2021Shanghai I-Mab  Enters Two New Oncology Partnerships

7/11/2021Biocytogen/Eucure Biopharma's CTLA-4 and CD40 mAbs Approved for Phase ...

7/9/2021MOFCOM Plans to Beef Up Scrutinization of Foreign Investment

7/9/2021Takeda's NDA for Mobocertinib (TAK-788) Accepted in China as a Treatme...

7/9/2021Recent Executive Moves

7/9/2021Innovent's NDA for FGFR1/2/3 Inhibitor (Pemigatinib) Accepted in China...

7/9/2021Schott Inaugurates New Glass Tubing Plant in China

7/8/2021Parexel Expands A/P Capability with New China Depot Planned

Page:123/719 Total number of articles:21549: [First][<<] [121] [122] [123] [124] [125] [>>] [End]